Biogen Idec Partners with Isis Pharmaceuticals in $100M Drug Deal

Source: Bloomberg Businessweek

Sep 10, 2013

Biogen Idec Inc., maker of the multiple sclerosis pill Tecfidera, expanded its partnership with Isis Pharmaceuticals Inc. in a deal to develop drugs for neurological disorders. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments